Bogotá, Colombia–(Newsfile Corp. – May 14, 2021) – Medcolcanna Organics Inc. (TSXV: MCCN) (“Medcolcanna“, “MCCN” or the “Company“), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, May 19, 2021 at 11:00 a.m. (Bogota time) at the offices of the Company will be postponed to a later date, with details of the new date and time to be provided in a future news release. The Company expects that some of the items of business to be voted on may change and is therefore delaying the meeting in order to allow for the provision of new materials to the shareholders in conjunction with the meeting.
Medcolcanna is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which positions the Company to become a global leader in the medical cannabis market.
Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company’s scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.
Felipe de la Vega, CEO: “We have developed a resilient and adaptive company that has quietly walked the talk and built strong basis for success with solid local partnerships for the medicinal industry, ample experience gathered to expand and monetize our current international commodities distribution and the fundamentals in place to move into the larger pharma industry. Hard work and strong commitment have taken us here and we will relentlessly continue to fulfill our mission to bring high quality cannabis based products at highly competitive prices in order to help improve several medical conditions for patients in need.”
Additional information about Medcolcanna can be found on its web site at www.medcolcanna.com
Investor Relations Contact:
Chris Reid, CFO
Carrera 49b # 93-62
Felipe de la Vega, CEO
Carrera 49b # 93-62
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/84206